glp 1 for eating disorders Experts express alarm that GLP-1 RAs may trigger or worsen disorders. But is there any role they might play in binge eating disorder? And how can clinicians protect patients from risk? GLP-1 RAs in Eating Disorders:
Description
Are Metabolic Markers Documented
Retatrutide: Phase-2 trial Retatrutide is an investigational triple agonist (GLP-1, GIP and glucagon receptors), adding a third hormone target to potentially boost metabolism further

doi: 10.1016/j.bbapap.2006.08.001 278 BaggioLLDruckerDJ

Founds pricing system offers options, but not much clarity
